ПРИМЕНЕНИЕ УРАПИДИЛА В ИНТРАОПЕРАЦИОННОМ ПЕРИОДЕ У БОЛЬНЫХ С РАСПРОСТРАНЕННЫМ АТЕРОСКЛЕРОЗОМ И ВЫСОКИМ ОПЕРАЦИОННО-АНЕСТЕЗИОЛОГИЧЕСКИМ РИСКОМ
И. Е. Голуб, Sorokina Lv, Новиков Алексей Юрьевич et al. · Pacific Medical Journal · 2013
The paper provides prospective controlled randomised examination of 57 men undergone aortobifemoral bypass surgery on chronic occlusive arterial disease of limbs associated with widespread atherosclerosis. Urapidil was used to correct pre- and intraoperative resistant hypertension in 29 patients of the impact group. Enalaprilat was used to treat patients in the control group. The target values of arterial pressure were achieved in 92 % of cases in the impact group and in 74 % of cases in the control group.
Cited by 0 works.